The U.S. patent system is a cornerstone of economic growth and technological advancement, particularly for small businesses, ...

Biosimilars hold the potential to dramatically lower health care costs and improve access to life-changing treatments, but ...

China doesn't play by the rules when it comes to intellectual property. Former Congressman Lamar Smith writes that Congress ...

In 2024, autonomous vehicle (AV) tech in the U.S. hasgained renewed momentum after a two-year stall. Despite setbacks, ...

Ken D. Kumayama and Pramode Chiruvolu of Skadden, Arps, Slate, Meagher & Flom LLP discuss intellectual property protections ...

Part 1 of this 3-part series for Global Biosimilars Week focuses on legal barriers to biosimilar access in the US, including the patent system, and discusses ongoing legislative efforts to address ...

What started off as a dice roll of a new practice group at Russ August & Kabat has turned into the breadwinner of the ...

Donald Trump’s return to the White House has reignited calls for a free trade deal between the UK and the US. Shortly after ...

“However, cost remains a significant concern ... “Generally, we expect prices to crash in the range of 80 to 90% after the ...

At times, the cycling patent news cycle feels intense and a little relentless. A patent for exciting new components or some ...

Today, Palworld developer Pocketpair published a report detailing the terms of the intellectual property lawsuit Nintendo ...

Palworld developer Pocket Pair has explained the details of Nintendo's patent infringement lawsuit against it, and the ...